199 related articles for article (PubMed ID: 3912600)
1. [Pressure lowering effect and side effects of 0.5% and 1.0% levobunolol eyedrops, compared with 0.5% timolol eyedrops in patients with open-angle glaucoma].
Stryz JR; Merté HJ
Klin Monbl Augenheilkd; 1985 Dec; 187(6):537-44. PubMed ID: 3912600
[TBL] [Abstract][Full Text] [Related]
2. [Comparison of the effectiveness and safety of levobunolol and timolol in ocular hypertension and chronic open-angle glaucoma].
Freyler H; Novack GD; Menapace R; Skorpik C; Mordaunt J; Batoosingh AL
Klin Monbl Augenheilkd; 1988 Sep; 193(3):257-60. PubMed ID: 3070134
[TBL] [Abstract][Full Text] [Related]
3. [Comparative study of levobunolol and timolol in the treatment of chronic open-angle glaucoma and chronic ocular hypertension].
Savelsbergh-Fillette MP; Demailly P
J Fr Ophtalmol; 1988; 11(8-9):587-90. PubMed ID: 2906644
[TBL] [Abstract][Full Text] [Related]
4. [The effect of levobunolol eyedrops on trabecular outflow of aqueous humor in chronic simple glaucoma].
Călugăru M
Klin Monbl Augenheilkd; 1989 Mar; 194(3):164-9. PubMed ID: 2657200
[TBL] [Abstract][Full Text] [Related]
5. Levobunolol compared with timolol for the control of elevated intraocular pressure.
Geyer O; Lazar M; Novack GD; Lue JC; Duzman E
Ann Ophthalmol; 1986 Oct; 18(10):289-90, 292. PubMed ID: 3535611
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of twice-daily levobunolol in the treatment of elevated intraocular pressure.
Seamone C; LeBlanc R; Saheb N; Novack G
Can J Ophthalmol; 1988 Jun; 23(4):168-70. PubMed ID: 3293726
[TBL] [Abstract][Full Text] [Related]
7. A comparison of the efficacy and tolerability of 0.5% timolol maleate ophthalmic gel-forming solution QD and 0.5% levobunolol hydrochloride BID in patients with ocular hypertension or open-angle glaucoma.
Halper LK; Johnson-Pratt L; Dobbins T; Hartenbaum D
J Ocul Pharmacol Ther; 2002 Apr; 18(2):105-13. PubMed ID: 12002664
[TBL] [Abstract][Full Text] [Related]
8. A 12-month, randomized, double-masked study comparing latanoprost with timolol in pigmentary glaucoma.
Mastropasqua L; Carpineto P; Ciancaglini M; Gallenga PE
Ophthalmology; 1999 Mar; 106(3):550-5. PubMed ID: 10080213
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of once-daily levobunolol for glaucoma therapy.
Rakofsky SI; Lazar M; Almog Y; LeBlanc RP; Mann C; Orr A; Lee PF; Friedland BR; Novack GD; Kelley EP
Can J Ophthalmol; 1989 Feb; 24(1):2-6. PubMed ID: 2653592
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of once-daily levobunolol 0.25% and timolol 0.25% therapy for increased intraocular pressure.
Silverstone D; Zimmerman T; Choplin N; Mundorf T; Rose A; Stoecker J; Kelley E; Lue J
Am J Ophthalmol; 1991 Jul; 112(1):56-60. PubMed ID: 1882923
[TBL] [Abstract][Full Text] [Related]
11. Levobunolol. A beta-adrenoceptor antagonist effective in the long-term treatment of glaucoma. The Levobunolol Study Group (Appended).
Ophthalmology; 1985 Sep; 92(9):1271-6. PubMed ID: 2865710
[TBL] [Abstract][Full Text] [Related]
12. The influence of diclofenac ophthalmic solution on the intraocular pressure-lowering effect of topical 0.5% timolol and 0.005% latanoprost in primary open-angle glaucoma patients.
Costagliola C; Parmeggiani F; Antinozzi PP; Caccavale A; Cotticelli L; Sebastiani A
Exp Eye Res; 2005 Nov; 81(5):610-5. PubMed ID: 15949795
[TBL] [Abstract][Full Text] [Related]
13. The safety and efficacy of travoprost 0.004%/timolol 0.5% fixed combination ophthalmic solution.
Barnebey HS; Orengo-Nania S; Flowers BE; Samples J; Mallick S; Landry TA; Bergamini MV
Am J Ophthalmol; 2005 Jul; 140(1):1-7. PubMed ID: 15990081
[TBL] [Abstract][Full Text] [Related]
14. Effect of varying drop size on the efficacy and safety of a topical beta blocker.
Charap AD; Shin DH; Petursson G; Cinotti D; Wortham E; Brown RH; Silverstone DE; Atkins JM; Eto CY; Lue JC
Ann Ophthalmol; 1989 Sep; 21(9):351-7. PubMed ID: 2683937
[TBL] [Abstract][Full Text] [Related]
15. A 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0:005%/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.
Franks WA; Renard JP; Cunliffe IA; Rojanapongpun P
Clin Ther; 2006 Mar; 28(3):332-9. PubMed ID: 16750448
[TBL] [Abstract][Full Text] [Related]
16. The safety and efficacy of brinzolamide 1%/timolol 0.5% fixed combination versus dorzolamide 2%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension.
Manni G; Denis P; Chew P; Sharpe ED; Orengo-Nania S; Coote MA; Laganovska G; Volksone L; Zeyen T; Filatori I; James J; Aung T
J Glaucoma; 2009; 18(4):293-300. PubMed ID: 19365194
[TBL] [Abstract][Full Text] [Related]
17. Dorzolamide/timolol combination versus concomitant administration of brimonidine and timolol: six-month comparison of efficacy and tolerability.
Sall KN; Greff LJ; Johnson-Pratt LR; DeLucca PT; Polis AB; Kolodny AH; Fletcher CA; Cassel DA; Boyle DR; Skobieranda F
Ophthalmology; 2003 Mar; 110(3):615-24. PubMed ID: 12623832
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of 0.5% timolol maleate ophthalmic gel-forming solution QD compared with 0.5% levobunolol hydrochloride BID in patients with open-angle glaucoma or ocular hypertension.
Walters TR; Maloney S; Slater D; Liss C; Wilson H; Hartenbaum D
Clin Ther; 1998; 20(6):1170-8. PubMed ID: 9916610
[TBL] [Abstract][Full Text] [Related]
19. Levobunolol. A four-year study of efficacy and safety in glaucoma treatment. The Levobunolol Study Group.
Ophthalmology; 1989 May; 96(5):642-5. PubMed ID: 2664628
[TBL] [Abstract][Full Text] [Related]
20. Long-term ocular hypotensive effect of levobunolol: results of a one-year study.
Ober M; Scharrer A; David R; Biedner BZ; Novack GD; Lue JC; Robins DS; Duzman E
Br J Ophthalmol; 1985 Aug; 69(8):593-9. PubMed ID: 3893528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
